Hospitalizations in patients with atrial fibrillation: an analysis from ROCKET AF

AIMS: The high costs associated with treatment for atrial fibrillation (AF) are primarily due to hospital care, but there are limited data to understand the reasons for and predictors of hospitalization in patients with AF. METHODS AND RESULTS: The ROCKET AF trial compared rivaroxaban with warfarin...

Descripción completa

Detalles Bibliográficos
Autores principales: DeVore, Adam D., Hellkamp, Anne S., Becker, Richard C., Berkowitz, Scott D., Breithardt, Guenter, Hacke, Werner, Halperin, Jonathan L., Hankey, Graeme J., Mahaffey, Kenneth W., Nessel, Christopher C., Singer, Daniel E., Fox, Keith A. A., Patel, Manesh R., Piccini, Jonathan P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974633/
https://www.ncbi.nlm.nih.gov/pubmed/27174904
http://dx.doi.org/10.1093/europace/euv404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974633/
https://www.ncbi.nlm.nih.gov/pubmed/27174904
http://dx.doi.org/10.1093/europace/euv404

Ejemplares similares